Skip to main content

Table 2 Efficacy of treatment

From: Managing an effective treatment for neuroleptic malignant syndrome

 

Effectiveness on the basis of increase of dosage

Relapse on the basis of decrease of dosage

Improvement of symptoms

   

Fever

Rigor

Both

Not mentioned

Dantrolene monotherapy

2/37 (5.4%)

3/37 (8.1%)

9 (24.3%)

4 (10.8%)

9 (24.3%)

15 (40.5%)

Dantrolene with additive medication

5/82 (6.1%)

7/82 (8.5%)

10 (12.2%)

3 (3.7%)

12 (14.6%)

57 (69.5%)

Other medication

4/101 (4.0%)

17/101 (16.8%)

12 (11.9%)

2 (2.0%)

14 (13.9%)

73 (72.3%)

Only supportive therapy

Not applicable

Not applicable

1 (2.0%)

-

1 (2.0%)

49 (96.1%)